Navigation Links
The Conference Forum Launches 1st Dedicated Biotech Chief Medical Officer Newsletter
Date:5/30/2020

The Conference Forum is pleased to announce the launch of Chief Medical Officer 360°, the first newsletter solely dedicated to the unique role of the Chief Medical Officer in the biotech industry. The newsletter will capture a wide range of perspectives on the responsibilities, problem-solving, best practices and career development of CMOs and Heads of R&D from different therapeutic areas in the US and around the world. Physician scientists and others serving in biotech will also benefit from the expertise of leaders in the community.

“Chief Medical Officers are responsible for a vast number of R&D functions and we are excited to publish a quarterly newsletter specifically for this community,” said Andrew Goldstein, Editor of Chief Medical Officer 360°.

The inaugural issue will feature the following topics: the evolving role of the CMO through IPO; incorporating the patient perspective; enterprise management; developing treatments for SARS-CoV-2; advice for R&D leaders in challenging times; and partnering effectively with CROs. The issue ends with a recap from the archive: a session from the 2017 Chief Medical Officer Summit on How R&D Leadership Can Work More Collaboratively with Investors.

“CMOs are first and foremost responsible for patient safety and drive all R&D functions while supporting the CEO. We want to build more resources to help the CMO community interact and share peer-to-peer best practices,” said Valerie Bowling, Executive Director, the Conference Forum.

The following CMOs are featured in the inaugural issue: Dr Dana Hilt, CMO, Frequency Therapeutics, Dr Barry Ticho, CMO, Stoke Therapeutics, Dr Nerissa Kreher, CMO, Tiburio Therapeutics, Dr Beth Trehu, CMO, Jounce Therapeutics, Dr Akshay Vaishnaw, President, R&D, Alnylam, Dr Francisco Diaz-Mitoma, CMO, VBI Vaccines, and Dr Daniel Burch, Global Head, PPD Biotech.

The Conference Forum also presents the Chief Medical Officer Summit 360° two-day event and CMO-related podcasts. With the conferences, podcasts and quarterly newsletters, the company provides helpful insights and ongoing support for the CMO and R&D leadership community.

About the Conference Forum:
The Conference Forum is a research firm and develops specialized content for professionals in the life science and healthcare industries. The company currently offers conferences and newsletters for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum's mission is to create the best content, facilitate the exchange of ideas and provide quality networking to help move therapeutics to patients faster. Learn more about The Conference Forum at https://theconferenceforum.org.

Read the full story at https://www.prweb.com/releases/the_conference_forum_launches_1st_dedicated_biotech_chief_medical_officer_newsletter/prweb17157380.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
2. Annual Conference about Technology Solutions for People with Disabilities Announces Program
3. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
5. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
6. Palatin Technologies To Present At The 25th Annual ROTH Conference
7. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
8. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
9. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
10. Life Sciences Technology Conference and Career Fair on March 26th in Raleigh, NC
11. Neogen Corporation Announces 3rd Quarter Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):